These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16815250)

  • 1. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease.
    Flynn JT; Chan-Ling T
    Am J Ophthalmol; 2006 Jul; 142(1):46-59. PubMed ID: 16815250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
    Huang ZN; Yin DM; Huang DR; Liang SX
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of avascular peripheral retina in older prematurely born infants.
    Ho LY; Ho V; Aggarwal H; Ranchod TM; Capone A; Trese MT; Drenser KA
    Retina; 2011; 31(7):1248-54. PubMed ID: 21358456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small foveal avascular zone may be an historic mark of prematurity.
    Mintz-Hittner HA; Knight-Nanan DM; Satriano DR; Kretzer FL
    Ophthalmology; 1999 Jul; 106(7):1409-13. PubMed ID: 10406630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
    Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
    Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
    Kychenthal A; Dorta P; Katz X
    Retina; 2006 Sep; 26(7 Suppl):S11-5. PubMed ID: 16946670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography.
    Yokoi T; Hiraoka M; Miyamoto M; Yokoi T; Kobayashi Y; Nishina S; Azuma N
    Ophthalmology; 2009 Jul; 116(7):1377-82. PubMed ID: 19481811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2.
    Jalali S; Kesarwani S; Hussain A
    Am J Ophthalmol; 2011 Apr; 151(4):719-724.e2. PubMed ID: 21257156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach.
    Vinekar A; Trese MT; Capone A;
    Am J Ophthalmol; 2008 Mar; 145(3):548-555. PubMed ID: 18207120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.
    Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D
    Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and timing of treatment of zone I retinopathy of prematurity.
    Soh Y; Fujino T; Hatsukawa Y
    Am J Ophthalmol; 2008 Sep; 146(3):369-374. PubMed ID: 18602081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of diode treatment of active phase of retinopathy of prematurity].
    Gotz-Wieckowska A; Kociecki J; Burchardt-Kroll E; Gadzinowski J
    Klin Oczna; 2003; 105(6):395-7. PubMed ID: 15049263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryotherapy and photocoagulation in the treatment of retinopathy of prematurity].
    Autrata R; Holousová M; Rehůrek J
    Cesk Slov Oftalmol; 2002 Jan; 58(1):30-5. PubMed ID: 11852552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic changes and response to laser treatment in threshold retinopathy of prematurity: 10-year experience.
    Kim JE; Lee AC
    J Pediatr Ophthalmol Strabismus; 2010; 47(4):231-5. PubMed ID: 19791711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography.
    Yokoi T; Yokoi T; Kobayashi Y; Hiraoka M; Nishina S; Azuma N
    Am J Ophthalmol; 2009 Oct; 148(4):544-550.e1. PubMed ID: 19589496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.
    Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I
    Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical appearance and outcome of zone 1 retinopathy of prematurity (ROP)].
    Odehnal M; Malec J; Hlozánek M; Dotrelová D
    Cesk Slov Oftalmol; 2006 Sep; 62(5):316-23. PubMed ID: 17039918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zone I retinopathy of prematurity.
    Katz X; Kychenthal A; Dorta P
    J AAPOS; 2000 Dec; 4(6):373-6. PubMed ID: 11124674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinopathy of prematurity: clinic and pathogenesis. Disproportion between apoptosis of vitreal and proliferation of retinal vascularization.
    Pau H
    Ophthalmologica; 2008; 222(4):220-4. PubMed ID: 18463422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity.
    Lepore D; Molle F; Pagliara MM; Baldascino A; Angora C; Sammartino M; Quinn GE
    Ophthalmology; 2011 Jan; 118(1):168-75. PubMed ID: 20709401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.